Durvalumab vs Oseltamivir

## Durvalumab vs Oseltamivir: Overview

This comparison examines the pharmacological differences between **Durvalumab** and **Oseltamivir**.

## Mechanism of Action

**Durvalumab**: Human IgG1 kappa anti-PD-L1 monoclonal antibody blocking PD-L1 binding to PD-1 and CD80.

**Oseltamivir**: Neuraminidase inhibitor preventing viral release from host cells.

## Pharmacokinetics

**Half-life**: Durvalumab — 17 days; Oseltamivir — 6-10 hours.

## Chemical Properties

**Molecular Formula**: Durvalumab — N/A; Oseltamivir — C16H28N2O4.

**Molecular Weight**: Durvalumab — N/A; Oseltamivir — 312.4050 g/mol.

**Type**: Durvalumab — Antibody; Oseltamivir — Small molecule.